San Francisco -- For the past five days people with diabetes have taken
over downtown San Francisco. More than 20,000 diabetes professionals
have been here for the annual meeting of the American Diabetes
Association. Those of us wearing ADA name badges not only filled the
exhibition halls but also San Francisco's already crowded sidewalks. The
city was a gracious hostess, providing the best possible accommodations
and weather. We met in in the city's largest convention and exhibition
complex, the Moscone Center . Built in 1981, the center is named for George Moscone, a former mayor of San Francisco who was assassinated in 1978.
Moscone Center Entrance This
vibrant city itself explains a lot why for me this was the best ADA
ever. It almost tempts me to move back to California and to live in a
big city again. But now we are leaving. I tried to stop this bus, but
Stop the Bus!
was here a dozen years ago that the ADA introduced us to new
terminology describing the types of diab...
To decide which health insurance plan is best for you, you need to determine how much you will be spending on medical care in the future. There are two ways to estimate your future costs: 1) Starting from scratch and estimating how much you will probably spend using average costs for the medical procedures you think you’ll need. 2) Looking at your Explanation of Benefits (EOBs) from last year to see what medical coverage you required, and guessing that the next year will be similar. If you’re starting from scratch, first list all the doctor visits, hospital visits (such as out-patient surgery), prescription drugs, laboratory tests, immunizations, x-rays, or other medical services you may seek in the next year. Then, multiply your expected number of visits, prescriptions, etc. by the average costs in the table below. (For quick explanations of terms like EOBs, co-pay, deductible, and co-insurance, check out our Health Insurance Glossary .) Doctor Visits (co-pay) - $30 per visit P...
The Food and Drug Administration surprised almost everyone on March 24 by approving the DexCom STS Continuous Glucose Monitoring System . Even DexCom’s President and CEO Andrew Rasdal seems to have been surprised.
He told analysts in a conference call on March 27 that he had expected an “approvable letter” requesting more information. I was surprised as anyone, even though a few months ago I bought stock in the company.
Even more surprising is that Rasdal says that they will start selling the STS system immediately and anywhere in the country. This is in marked contrast to the Medtronic Diabetes marketing strategy for the other continuous sensor, the Guardian RT. While it works out the reimbursement issue, Medtronic is limiting sales to just seven large cites .
Getting health insurance coverage is the big challenge for all continuous sensors simply because they are so expensive. Rasdal told analysts that those of us who can afford the out-of-pocket costs will be the company’s first ...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.